Oivi is a health care startup based in Norway, founded in 2017. The company's mission is to prevent blindness among diabetes patients through the deployment of an AI-camera for automated diagnosis of retinal diseases. Oivi has received a significant boost with its latest funding round of kr16.00M in grant investment on 14 February 2023, with the backing of the Norwegian Research Council.
Oivi's innovative approach to leveraging AI technology for early detection and intervention in retinal diseases holds promising potential for addressing a critical healthcare challenge. The company's focus on preventing blindness due to diabetes resonates with the growing demand for advanced solutions in diabetic care and ocular health.
With its strong technological foundation and strategic partnerships, Oivi is well-positioned to make a meaningful impact in the field of preventive healthcare. The recent investment from the Norwegian Research Council not only validates the potential of Oivi's solution but also provides the necessary resources for the startup to scale its operations and reach a wider patient base. The support from a notable institution further underscores the significance of Oivi's efforts in combating diabetic-related blindness.